Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Pressure and stress transients in autoinjector devices.

Veilleux JC, Shepherd JE.

Drug Deliv Transl Res. 2018 Oct;8(5):1238-1253. doi: 10.1007/s13346-018-0568-7.

PMID:
30084014
2.

Understanding women's hesitancy to undergo less frequent cervical cancer screening.

Gerend MA, Shepherd MA, Kaltz EA, Davis WJ, Shepherd JE.

Prev Med. 2017 Feb;95:96-102. doi: 10.1016/j.ypmed.2016.11.028. Epub 2016 Dec 6.

PMID:
27932055
3.

Analysis of focused laser differential interferometry.

Schmidt BE, Shepherd JE.

Appl Opt. 2015 Oct 1;54(28):8459-72. doi: 10.1364/AO.54.008459.

PMID:
26479624
4.

Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.

Gerend MA, Shepherd MA, Lustria ML, Shepherd JE.

Sex Transm Infect. 2016 Mar;92(2):104-7. doi: 10.1136/sextrans-2015-052088. Epub 2015 Aug 21.

PMID:
26297720
5.

Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior.

Gerend MA, Shepherd JE.

Ann Behav Med. 2012 Oct;44(2):171-80. doi: 10.1007/s12160-012-9366-5. Erratum in: Ann Behav Med. 2012 Oct;44(2):293.

6.

The multidimensional nature of perceived barriers: global versus practical barriers to HPV vaccination.

Gerend MA, Shepherd MA, Shepherd JE.

Health Psychol. 2013 Apr;32(4):361-9. doi: 10.1037/a0026248. Epub 2011 Nov 7.

7.

Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women.

Gerend MA, Shepherd JE.

Women Health. 2011 Jan;51(1):25-40. doi: 10.1080/03630242.2011.540744.

8.

Behavioral frequency moderates the effects of message framing on HPV vaccine acceptability.

Gerend MA, Shepherd JE, Monday KA.

Ann Behav Med. 2008 Apr;35(2):221-9. doi: 10.1007/s12160-008-9024-0. Epub 2008 Mar 12.

PMID:
18347893
9.

Using message framing to promote acceptance of the human papillomavirus vaccine.

Gerend MA, Shepherd JE.

Health Psychol. 2007 Nov;26(6):745-52.

PMID:
18020847
10.

Predictors of human papillomavirus vaccination acceptability among underserved women.

Gerend MA, Lee SC, Shepherd JE.

Sex Transm Dis. 2007 Jul;34(7):468-71.

PMID:
17139233
11.

Proliferation of electronic health records among obstetrician-gynecologists.

Menachemi N, Lee SC, Shepherd JE, Brooks RG.

Qual Manag Health Care. 2006 Jul-Sep;15(3):150-6.

PMID:
16849986
12.

Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women.

Huttner RP, Shepherd JE.

Med Clin North Am. 2003 Sep;87(5):1065-76. Review.

PMID:
14621331
13.

Teaching patients the ABCs of preventing melanoma.

Shepherd JE.

J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):325-6. No abstract available.

PMID:
12688443
14.

Implementing new guidelines to prevent sexually transmitted diseases.

Shepherd JE.

J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6):884-5. No abstract available.

PMID:
12482015
15.

Pharmacy-based care for perimenopausal and postmenopausal women.

Shepherd JE, Bopp J.

J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):700-11; quiz 711-2. Review.

PMID:
12269705
16.

Therapeutic options in female sexual dysfunction.

Shepherd JE.

J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):479-87; quiz 487-8. Review.

PMID:
12030635
17.

Hormone replacement therapy: separating fact from fallacy.

Shepherd JE.

J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):122-3. Review. No abstract available.

PMID:
11833505
18.

Immunizations for high-risk populations.

Shepherd JE, Grabenstein JD.

J Am Pharm Assoc (Wash). 2001 Nov-Dec;41(6):839-49; quiz 923-5. Review. No abstract available.

PMID:
11765109
19.

Effects of estrogen on congnition mood, and degenerative brain diseases.

Shepherd JE.

J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):221-8. Review.

PMID:
11297335
20.

Decision analysis for the cost-effective management of recurrent colorectal cancer.

Park KC, Schwimmer J, Shepherd JE, Phelps ME, Czernin JR, Schiepers C, Gambhir SS.

Ann Surg. 2001 Mar;233(3):310-9.

21.

A review of the literature for whole-body FDG PET in the management of patients with melanoma.

Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, Phelps ME, Czernin J, Gambhir SS.

Q J Nucl Med. 2000 Jun;44(2):153-67.

PMID:
10967625
22.

A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS.

J Nucl Med. 2000 Jul;41(7):1177-89.

23.

Current strategies for prevention, detection, and treatment of ovarian cancer.

Shepherd JE.

J Am Pharm Assoc (Wash). 2000 May-Jun;40(3):392-401. Review.

PMID:
10853541
24.

Analytical decision model for the cost-effective management of solitary pulmonary nodules.

Gambhir SS, Shepherd JE, Shah BD, Hart E, Hoh CK, Valk PE, Emi T, Phelps ME.

J Clin Oncol. 1998 Jun;16(6):2113-25.

PMID:
9626211
25.

MD@: a physician-friendly decision analysis tool.

Gambhir SS, Gupta P, Shepherd JE, Allen MA, Hoh C, Maddahi J, Phelps ME.

MD Comput. 1998 Jan-Feb;15(1):40-8.

PMID:
9458662
26.

Exenteration as palliation for patients with advanced pelvic malignancy.

Woodhouse CR, Plail RO, Schlesinger PE, Shepherd JE, Hendry WF, Breach NM.

Br J Urol. 1995 Sep;76(3):315-20.

PMID:
7551839

Supplemental Content

Loading ...
Support Center